{
    "organizations": [],
    "uuid": "1f89e54cf4f473645940e1ee8d08707281787522",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-zhejiang-jolly-pharmaceutical-unit/brief-zhejiang-jolly-pharmaceutical-unit-to-set-up-industry-buyout-fund-to-invest-in-biomedicine-firm-idUSL3N1PC3D1",
    "ord_in_thread": 0,
    "title": "BRIEF-Zhejiang Jolly Pharmaceutical unit to set up industry buyout fund to invest in biomedicine firm",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 17(Reuters) - Zhejiang Jolly Pharmaceutical Co Ltd\n* Says co’s wholly owned medical unit to set up an industry buyout fund with partner to invest in a Shanghai-based biomedicine firm, with fund’s investment amount of up to 120 million yuan\n* Says unit is holding 7.85 percent stake in the Shanghai-based biomedicine firm\nSource text in Chinese: goo.gl/5coZzb\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-01-17T17:59:00.000+02:00",
    "crawled": "2018-01-18T16:18:40.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "zhejiang",
        "jolly",
        "pharmaceutical",
        "co",
        "ltd",
        "say",
        "co",
        "wholly",
        "owned",
        "medical",
        "unit",
        "set",
        "industry",
        "buyout",
        "fund",
        "partner",
        "invest",
        "biomedicine",
        "firm",
        "fund",
        "investment",
        "amount",
        "million",
        "yuan",
        "say",
        "unit",
        "holding",
        "percent",
        "stake",
        "biomedicine",
        "firm",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}